Dr. Scott is one of the few individuals who has achieved greatness in their career journeys. For him, he has specialized as a biochemical researcher and a contemporary entrepreneur.
Among other achievements, Scott Rocklage is today a managing partner of 5AM Ventures, and this is a position that he rose to only a year after joining this company as a Managing Partner. His past experiences make him an outstanding professional in the healthcare industry, and he has been actively serving the industry for a period of about 3 decades.
Although Scott’s dedication and passion have made him become an icon in the healthcare industry, he has a rich academic background that supports his ability to make appropriate contributions. At the University of California, Dr. Scott Rocklage graduated with a Bachelor’s degree in Chemistry.
Furthermore, he relentlessly piled up his knowledge and certificates by furthering his education at the Massachusetts Institute of Technology for a Doctor of Philosophy Degree in Chemistry. It is in this institution that his teamwork abilities enabled him together with Richard R. Schrock to win a Nobel Prize in 2005. Read more: Scott Rocklage | Bloomberg and Scott Rocklage | Ideamesch
Besides working for 5AM Ventures and other companies, the personal contributions of Dr. Scott Rocklage cannot go unnoticed. Within his 3 decades career, he spearheaded the approval of the various New Drugs Application including Onmiscam, Cubicin, and Teslascan by the FDA.
Additionally, he has kicked in to ensure the adoption of 6 additional drugs candidates into clinical tests. To date, over 100 publications have been authored by Dr. Scott, and he has played a significant role in the patenting of over thirty patents.
In reference to his academic excellence, passion, and hard work, Scott Rocklage has held senior positions in a slew of companies. For instance, in Cubist Pharmaceuticals, he doubled as the Chairman and Chief Executive Officer.
He held the President’s position of Nycomed Salutar, and he was also a senior person Salutar and Catalytica. Before Ilypsa was acquired by Amgen, he served as its executive chairman, and the same applies to Miikana whose ownership eventually transferred to Teleflex. The office of Dr. Scott Rocklage is situated in Boston, MA office
Learn more about Scott Rocklage: